Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients

Journal of Diabetes and its Complications

Volumn 28, Issue 5, 2014, Pages 729-734

  Hirano, Takao ^a,b   Iesato, Yasuhiro ^a   Toriyama, Yuichi ^a   Imai, Akira ^a   Chiba, Dai ^a,b   Murata, Toshinori ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Omachi General Hospital   (Japan)

Author keywords

Advanced glycation end product; Diabetic macular edema; Diabetic retinopathy; Skin autofluorescence; Type 2 diabetes mellitus; Vascular endothelial growth factor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN A1C; BIOLOGICAL MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AUTOFLUORESCENCE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETIC MACULAR EDEMA; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; OPHTHALMOSCOPY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; SKIN AUTOFLUORESCENCE; SKIN EXAMINATION; SKIN PIGMENTATION; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; FLUORESCENCE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SKIN;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84906794357     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2014.03.003     Document Type: Article

References (35)

1. L.P. Aiello, R.L. Avery, P.G. Arrigg, B.A. Keyt, H.D. Jampel, and S.T. Shah et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders New England Journal of Medicine 331 22 1994 1480 1487
2. S. Chabroux, F. Canoui-Poitrine, S. Reffet, G. Mills-Joncour, E. Morelon, and C. Colin et al. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy Diabetes Metabolism 36 2 2010 152 157
3. P.A. Cleary, B.H. Braffett, T. Orchard, T.J. Lyons, J. Maynard, and C. Cowie et al. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Diabetes Technology & Therapeutics 15 6 2013 466 474
4. L.C. de Vos, M.J. Noordzij, D.J. Mulder, A.J. Smit, H.L. Lutgers, and R.P. Dullaart et al. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease Arteriosclerosis, Thrombosis, and Vascular Biology 33 1 2013 131 138
5. T.B. Fitzpatrick The validity and practicality of sun-reactive skin types I through VI Archives of Dermatology 124 6 1988 869 871
6. S. Genuth, W. Sun, P. Cleary, D.R. Sell, W. Dahms, and J. Malone et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes Diabetes 54 11 2005 3103 3111
7. E.G. Gerrits, H.L. Lutgers, N. Kleefstra, R. Graaff, K.H. Groenier, and A.J. Smit et al. Skin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular complications Diabetes Care 31 2008 517 521
8. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 6 2006 597 605
9. J. Grauslund Long-term mortality and retinopathy in type 1 diabetes Acta Ophthalmologica 88 2010 1 14 (Thesis1)
10. J.A. Haller Current anti-vascular endothelial growth factor dosing regimens: benefits and burden Ophthalmology 120 5 Suppl. 2013 S3 S7
11. M.I. Harris, R. Klein, T.A. Welborn, and M.W. Knuiman Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis Diabetes Care 15 7 1992 815 819
12. A.S. Januszewski, N. Sachithanandan, C. Karschimkus, D.N. O'Neal, C.K. Yeung, and N. Alkatib et al. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction Diabetic Medicine 29 6 2012 726 733
13. M. Kerkeni, A. Saidi, H. Bouzidi, S. Ben Yahya, and M. Hammami Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy Microvascular Research 84 3 2012 378 383
14. R. Klein, B.E. Klein, and S.E. Moss The Wisconsin epidemiological study of diabetic retinopathy: a review Diabetes/Metabolism Reviews 5 7 1989 559 570
15. R. Klein, B.E. Klein, S.E. Moss, and K.J. Cruickshanks The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema Ophthalmology 102 1 1995 7 16
16. R. Klein, B.E. Klein, S.E. Moss, M.D. Davis, and D.L. DeMets The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years Archives of Ophthalmology 102 4 1984 520 526
17. A.Y. Maa, and B.R. Sullivan Relationship of hemoglobin A1C with the presence and severity of retinopathy upon initial screening of Type II diabetes mellitus American Journal of Ophthalmology 144 3 2007 456 457
18. R. Meerwaldt, R. Graaff, P.H. Oomen, T.P. Links, J.J. Jager, and N.L. Alderson et al. Simple non-invasive assessment of advanced glycation endproduct accumulation Diabetologia 47 7 2004 1324 1330
19. R. Meerwaldt, J.W. Hartog, R. Graaff, R.J. Huisman, T.P. Links, and N.C. den Hollander et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients Journal of the American Society of Nephrology 16 12 2005 3687 3693
20. R. Meerwaldt, H.L. Lutgers, T.P. Links, R. Graaff, J.W. Baynes, and R.O. Gans et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes Diabetes Care 30 1 2007 107 112
21. R. Milne, and S. Brownstein Advanced glycation end products and diabetic retinopathy Amino Acids 44 6 2013 1397 1407
22. V.M. Monnier, O. Bautista, D. Kenny, D.R. Sell, J. Fogarty, and W. Dahms et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial Diabetes 48 4 1999 870 880
23. V.M. Monnier, V. Vishwanath, K.E. Frank, C.A. Elmets, P. Dauchot, and R.R. Kohn Relation between complications of type I diabetes mellitus and collagen-linked fluorescence New England Journal of Medicine 314 7 1986 403 408
24. D.J. Mulder, M. Bieze, R. Graaff, A.J. Smit, and J.M. Hooymans Skin autofluorescence is elevated in neovascular age-related macular degeneration British Journal of Ophthalmology 94 5 2010 622 625
25. T. Murata, T. Ishibashi, A. Khalil, Y. Hata, H. Yoshikawa, and H. Inomata Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels Ophthalmic Research 27 1 1995 48 52
26. T. Murata, R. Nagai, T. Ishibashi, H. Inomuta, K. Ikeda, and S. Horiuchi The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas Diabetologia 40 7 1997 764 769
27. T. Murata, K. Nakagawa, A. Khalil, T. Ishibashi, H. Inomata, and K. Sueishi The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas Laboratory Investigation 74 4 1996 819 825
28. T.J. Orchard, T.J. Lyons, P.A. Cleary, B.H. Braffett, J. Maynard, and C. Cowie et al. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study Diabetes Care 36 10 2013 3146 3153
29. J.B. Saaddine, A.A. Honeycutt, K.M. Narayan, X. Zhang, R. Klein, and J.P. Boyle Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050 Archives of Ophthalmology 126 12 2008 1740 1747
30. S.J. Sheu, N.C. Liu, L.P. Ger, W.L. Ho, J.Y. Lin, and S.C. Chen et al. High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration Graefe's Archive for Clinical and Experimental Ophthalmology 251 9 2013 2087 2092
31. The Diabetes Control and Complications Trial The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial Diabetes 44 8 1995 968 983
32. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group New England Journal of Medicine 329 14 1993 977 986
33. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 9131 1998 837 853
34. S.A. Vinores, A.I. Youssri, J.D. Luna, Y.S. Chen, S. Bhargave, and M.A. Vinores et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease Histology and Histopathology 12 1 1997 99 109
35. C.P. Wilkinson, F.L. Ferris III, R.E. Klein, P.P. Lee, C.D. Agardh, and M. Davis et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales Ophthalmology 110 9 2003 1677 1682